Pfizer and BioNTech’s Combo Shot Missed the Mark. Is It Time to Sell?
The Motley FoolA clinical-trial failure for Pfizer and BioNTech means Moderna is leading the race to develop a combo shot for the flu and COVID-19.
A clinical-trial failure for Pfizer and BioNTech means Moderna is leading the race to develop a combo shot for the flu and COVID-19.